This Lexicon Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Analysts initiate coverage: Buy on IonQ ($60), Jack Henry ($193) and 10X Genomics ($110); Overweight Lexicon ($8); In-Line Fortive ($60).
Stocks · News reference
Argus Research Reiterates Buy on Fortive, Maintains $68 Price Target
Argus Research analyst John Eade reiterates Fortive (NYSE:FTV) with a Buy and maintains $68 price target.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Evercore ISI Group Initiates Coverage On Fortive with In-Line Rating, Announces Price Target of $60
Evercore ISI Group analyst Alexander Virgo initiates coverage on Fortive (NYSE:FTV) with a In-Line rating and announces Price Target of $60.
8-K filing — Fortive Corp (FTV)
Filed: 2026-09-10 AccNo: 0001104659-26-106735 Size: 239 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Fortive Raises Quarterly Dividend From $0.06 To $0.07/Share, Payable September 25 To Holders Of Record September 4